Fidelity Biosciences

Fidelity Biosciences

Fidelity Biosciences

They are a division of Fidelity Investments, one of the world's leading providers of financial services.
Follow us
$60,000,000 Venture capital (Series D)
MedCity News , PE Hub

Quartet raises $60M Series D led by Centene


Recent departures hint at turmoil at Quartet Health, a mental health startup backed by GV

Funding Employment

TraceLink Bags $93M, Plans A.I. & Blockchain Tools for Drug Tracking

Funding Manufacturing Cloud

TraceLink just landed $60 million more to eliminate counterfeit prescription drugs

Funding Health
$100,000,000 Venture capital (Series E)

Iora Health Goes Big With $100M to Advance Collaborative Care Model

Health Funding

Iora Health Secures $100M in Series E Financing

Funding Health
MedCity News

Quartet Health CEO: The case for intertwining primary care and behavioral health

$10,000,000 Venture capital
MedCity News

Health IT startup Kyruus brings in $10M to support matching patients with providers


Boston Tech Watch: Kyruus, Kolide, Nano-C, BookingBug

$69,200,000 IPO
PE Hub

VC-backed Unum Therapeutics rolls out IPO

Stock markets Health

Unum Therapeutics IPO Raises $69M to Test Universal Cell Therapies

Health Stock markets
$45,000,000 Venture capital (Series C)

Quartet raises $40 million to bridge the physical and mental health care divide

Funding Health

With just one day left in open enrollment, companies turn to Stride Health for help

$23,500,000 Venture capital (Series B)
Venture Funding News , PE Hub , FinSMEs

Stride Health Pulls In $23.5M Series B Round

Added by
via Inc42

Healthcare Services Provider Medwell Ventures Secures $21 Mn Funding From Mahindra Capital

$21,000,000 Venture capital (Series B)
AVCJ , The Times of India

Mahindra leads $21m round for India's Medwell | AVCJ

$10,000,000 Venture capital
Drug Delivery Business , sec

Ivenix pulls down $10m tranche in $50m round

$15,000,000 Debt financing

Unum Therapeutics Receives $15M Credit Facility from Square 1 Bank

$26,100,000 Post-IPO equity
prnewswire , Crain's Cleveland Business

ViewRay Raises $26.1 Million in Private Placement

$125,000,000 Post-IPO debt

Biotech Day on Twitter